Coda Biotherapeutics

Developer of gene therapy-based analgesics for the treatment of neuropathic pain disorder

placeSan Francisco, California, United States calendar_todayFounded 2014 groups22 employees language codabiotherapeutics.com

Registered entities

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 214 times.

YearFilings
20171
20183
20194
20202
20212
20223
20242
20252
20261

Investor mix

6 investors on record; lead investors include Versant Ventures, Pacira.

Investor typeCountShare
Venture capital233%
Accelerator & incubator117%
Other / undisclosed350%
Coming soon